免疫学. 干扰素悖论。
Immunology. An interferon paradox.
机构信息
Institute for Immunology and Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
出版信息
Science. 2013 Apr 12;340(6129):155-6. doi: 10.1126/science.1237568.
Abstract
Interferons must balance antiviral actions against immunosuppressive effects during acute and chronic infections.
摘要
干扰素在急性和慢性感染期间必须平衡抗病毒作用和免疫抑制作用。
相似文献
1
Immunology. An interferon paradox.
Science. 2013 Apr 12;340(6129):155-6. doi: 10.1126/science.1237568.
2
Infection: the interferon paradox.
Nat Rev Immunol. 2013 Jun;13(6):392. doi: 10.1038/nri3461. Epub 2013 May 7.
3
Interfering with type I interferon: a novel approach to purge persistent viral infection.
Cell Cycle. 2013 Sep 15;12(18):2919-20. doi: 10.4161/cc.26175. Epub 2013 Aug 23.
4
Blockade of chronic type I interferon signaling to control persistent LCMV infection.
Science. 2013 Apr 12;340(6129):202-7. doi: 10.1126/science.1235208.
5
Persistent LCMV infection is controlled by blockade of type I interferon signaling.
Science. 2013 Apr 12;340(6129):207-11. doi: 10.1126/science.1235214.
6
Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling.
Immunity. 2005 Feb;22(2):247-57. doi: 10.1016/j.immuni.2005.01.005.
7
Immunosuppressive arenaviral exoribonuclease.
Oncotarget. 2015 Oct 20;6(32):32315-6. doi: 10.18632/oncotarget.6110.
8
Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection.
J Exp Med. 2005 Sep 5;202(5):637-50. doi: 10.1084/jem.20050821. Epub 2005 Aug 29.
9
Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon.
J Virol. 2011 Jun;85(12):5929-39. doi: 10.1128/JVI.02516-10. Epub 2011 Apr 6.
10
Viral persistence: parameters, mechanisms and future predictions.
Virology. 2006 Jan 5;344(1):111-8. doi: 10.1016/j.virol.2005.09.028.
引用本文的文献
1
CD8 T cells in the cancer-immunity cycle.
Immunity. 2023 Oct 10;56(10):2231-2253. doi: 10.1016/j.immuni.2023.09.005.
2
SARS CoV-2 infection as a risk factor of preeclampsia and pre-term birth. An interplay between viral infection, pregnancy-specific immune shift and endothelial dysfunction may lead to negative pregnancy outcomes.
Ann Med. 2023 Dec;55(1):2197289. doi: 10.1080/07853890.2023.2197289.
3
Low-dose exposure to PBDE disrupts genomic integrity and innate immunity in mammary tissue.
Front Genet. 2022 Aug 12;13:904607. doi: 10.3389/fgene.2022.904607. eCollection 2022.
4
Is IFN expression by NK cells a hallmark of severe COVID-19?
Cytokine. 2022 Sep;157:155971. doi: 10.1016/j.cyto.2022.155971. Epub 2022 Jul 22.
5
Anti-type I interferon antibodies as a cause of severe COVID-19.
Fac Rev. 2022 Jun 10;11:15. doi: 10.12703/r-01-0000010. eCollection 2022.
6
Understanding the Immune System in Fetal Protection and Maternal Infections during Pregnancy.
J Immunol Res. 2022 Jun 24;2022:7567708. doi: 10.1155/2022/7567708. eCollection 2022.
7
IFN-α blockade during ART-treated SIV infection lowers tissue vDNA, rescues immune function, and improves overall health.
JCI Insight. 2022 Mar 8;7(5):e153046. doi: 10.1172/jci.insight.153046.
8
Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk.
PLoS Pathog. 2021 Mar 15;17(3):e1009363. doi: 10.1371/journal.ppat.1009363. eCollection 2021 Mar.
9
Type I interferon signaling and macrophages: a double-edged sword?
Cell Mol Immunol. 2022 Sep;19(9):967-968. doi: 10.1038/s41423-020-00609-0. Epub 2021 Jan 8.
10
ISG15 protects human Tregs from interferon alpha-induced contraction in a cell-intrinsic fashion.
Clin Transl Immunology. 2020 Dec 23;9(12):e1221. doi: 10.1002/cti2.1221. eCollection 2020.
本文引用的文献
1
Persistent LCMV infection is controlled by blockade of type I interferon signaling.
Science. 2013 Apr 12;340(6129):207-11. doi: 10.1126/science.1235214.
2
Blockade of chronic type I interferon signaling to control persistent LCMV infection.
Science. 2013 Apr 12;340(6129):202-7. doi: 10.1126/science.1235208.
3
Pharmacology and therapeutic potential of interferons.
Pharmacol Ther. 2012 Jul;135(1):44-53. doi: 10.1016/j.pharmthera.2012.03.006. Epub 2012 Mar 28.
4
Immunomodulatory functions of type I interferons.
Nat Rev Immunol. 2012 Jan 6;12(2):125-35. doi: 10.1038/nri3133.
5
T cell exhaustion.
Nat Immunol. 2011 Jun;12(6):492-9. doi: 10.1038/ni.2035.
6
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.
Nature. 2010 Aug 19;466(7309):973-7. doi: 10.1038/nature09247.
7
Regulation of adaptive immunity by the innate immune system.
Science. 2010 Jan 15;327(5963):291-5. doi: 10.1126/science.1183021.
8
Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response.
J Clin Invest. 2009 Dec;119(12):3544-55. doi: 10.1172/JCI40093.
9
Multiple mechanisms contribute to impairment of type 1 interferon production during chronic lymphocytic choriomeningitis virus infection of mice.
J Immunol. 2009 Jun 1;182(11):7178-89. doi: 10.4049/jimmunol.0802526.
10
Viral evasion and subversion of pattern-recognition receptor signalling.
Nat Rev Immunol. 2008 Dec;8(12):911-22. doi: 10.1038/nri2436.
Zotero 插件